- Home
- GERN vs KOS Comparison
GERN vs KOS Comparison
Compare GERN & KOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GERN | KOS |
|---|---|---|
| Founded | 1990 | 2003 |
| Country | United States | United States |
| Employees | 229 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | GERN | KOS |
|---|---|---|
| Price | $1.46 | $2.52 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $2.17 | $1.76 |
| AVG Volume (30 Days) | 16.5M | ★ 17.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,288,352,000.00 |
| Revenue This Year | $32.27 | $17.57 |
| Revenue Next Year | $60.16 | $8.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.04 | $0.84 |
| 52 Week High | $2.01 | $2.55 |
Technical Indicators
Market Signals| Indicator | GERN | KOS |
|---|---|---|
| Relative Strength Index (RSI) | 41.84 | 72.24 |
| Support Level | $1.20 | $1.52 |
| Resistance Level | $1.68 | N/A |
| Average True Range (ATR) | 0.16 | 0.21 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 5.08 | 86.97 |
Price Performance
Historical ComparisonAbout GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About KOS Kosmos Energy Ltd. (DE)
Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.